knowledge -WSS

knowledge

author：comprehensive 2025-10-04 11:57:22 - browse：92

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： No plane should take off without an EpiPen onboard

focus

WSS

Guidelines to prevent youth baseball injuries need more muscle

DIEP, the 'gold standard' of breast reconstruction, is under threat

State Dept. review finds Biden bears some blame for Afghanistan failures

The high cost of giving birth even with insurance

Walensky prepares to leave CDC — and Congress — behind

Virginia high school admissions case could be legal follow

focus

knowledge

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

‘Oppenheimer’ and the risks of AI in health care

Jerome Adams on the need for new antivirals for Covid

Moonlake's readout produced a cash windfall. Risks remain

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Micronoma's microbiome cancer diagnostic approach under fire

Affirmative action in medical school literally saved lives

At least 13 dead in Texas as scorching temps continue

Tori Bowie and the unacceptable rates of Black maternal death

The high cost of giving birth even with insurance

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Adults seen as increasingly susceptible to measles

Heart attack and stroke risk calculators need revising

As demand for Covid shots wanes, Moderna seeks its next success

After affirmative action ruling, medical educators look to 'holistic review'

Jerome Adams on the need for new antivirals for Covid

hotspot

focus

explore

explore